LONDON, Nov 19 (Reuters) - GlaxoSmithKline said onTuesday it planned to reduce its investment in South Africandrugmaker Aspen Pharmacare, although it will retain aboard seat and significant shareholding.
Britain's biggest drugmaker intends to offload around 6percent of Aspen's issued share capital through a placing withinstitutional investors, leaving it with a stake of around 13percent.